Plasma microRNA levels in male and female children with cystic fibrosis

[1]  S. McColley,et al.  Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis , 2019, Scientific Reports.

[2]  R. Cui,et al.  Circulating MicroRNAs in Cancer: Potential and Challenge , 2019, Front. Genet..

[3]  C. Greene,et al.  Nebulised lipid–polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells , 2019, ERJ Open Research.

[4]  B. Xiao,et al.  The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3 , 2019, Oncogene.

[5]  M. Amaral,et al.  Prolonged co-treatment with HGF sustains epithelial integrity and improves pharmacological rescue of Phe508del-CFTR , 2018, Scientific Reports.

[6]  N. Rousselet,et al.  Small RNA and transcriptome sequencing reveal the role of miR‐199a‐3p in inflammatory processes in cystic fibrosis airways , 2018, The Journal of pathology.

[7]  C. Greene,et al.  Non-coding RNA in cystic fibrosis. , 2018, Biochemical Society transactions.

[8]  X. Su,et al.  MicroRNA in vivo precipitation identifies miR-151-3p as a computational unpredictable miRNA to target Stat3 and inhibits innate IL-6 production , 2017, Cellular & Molecular Immunology.

[9]  N. Parinandi,et al.  The expression of Mirc1/Mir17-92 cluster in sputum samples correlates with pulmonary exacerbations in cystic fibrosis patients. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[10]  Zhenqiu Liu,et al.  MicroRNA‐29c Prevents Pulmonary Fibrosis by Regulating Epithelial Cell Renewal and Apoptosis , 2017, American journal of respiratory cell and molecular biology.

[11]  Jochen H. M. Prehn,et al.  miRNAmeConverter: an R/bioconductor package for translating mature miRNA names to different miRBase versions , 2016, Bioinform..

[12]  M. Sohel,et al.  Extracellular/Circulating MicroRNAs: Release Mechanisms, Functions and Challenges , 2016 .

[13]  Andrew D. Rouillard,et al.  Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..

[14]  Hsien-Da Huang,et al.  miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database , 2015, Nucleic Acids Res..

[15]  E. Jimenez-Mateos,et al.  High Throughput qPCR Expression Profiling of Circulating MicroRNAs Reveals Minimal Sex- and Sample Timing-Related Variation in Plasma of Healthy Volunteers , 2015, PloS one.

[16]  I. Oglesby,et al.  miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production , 2015, European Respiratory Journal.

[17]  M. Amaral,et al.  A molecular switch in the scaffold NHERF1 enables misfolded CFTR to evade the peripheral quality control checkpoint , 2015, Science Signaling.

[18]  P. Lewindon,et al.  Circulating MicroRNAs as Noninvasive Diagnostic Biomarkers of Liver Disease in Children With Cystic Fibrosis , 2015, Journal of pediatric gastroenterology and nutrition.

[19]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[20]  C. Greene,et al.  Non-coding RNA as lung disease biomarkers , 2014, Thorax.

[21]  T. DeSantis,et al.  The Microbial Community of the Cystic Fibrosis Airway Is Disrupted in Early Life , 2014, PloS one.

[22]  A. Elliott,et al.  Gender differences in outcomes of patients with cystic fibrosis. , 2014, Journal of women's health.

[23]  Matthew N. McCall,et al.  On non-detects in qPCR data , 2014, Bioinform..

[24]  F. Ratjen,et al.  The cystic fibrosis gender gap: Potential roles of estrogen , 2014, Pediatric pulmonology.

[25]  Toby C. Cornish,et al.  A Critical Evaluation of microRNA Biomarkers in Non-Neoplastic Disease , 2014, PloS one.

[26]  Kieran McIntyre.  Early intervention to prevent obesity , 2013, Current opinion in pulmonary medicine.

[27]  M. Amaral,et al.  HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR. , 2013, ACS chemical biology.

[28]  T. Blondal,et al.  Assessing sample and miRNA profile quality in serum and plasma or other biofluids. , 2013, Methods.

[29]  David J. Galas,et al.  Comparing the MicroRNA Spectrum between Serum and Plasma , 2012, PloS one.

[30]  Matko Bosnjak,et al.  REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.

[31]  H. Pollard,et al.  Elevated miR-155 Promotes Inflammation in Cystic Fibrosis by Driving Hyperexpression of Interleukin-8* , 2011, The Journal of Biological Chemistry.

[32]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[33]  Peng-jun Zhang,et al.  Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies , 2010, Clinical science.

[34]  R. Day,et al.  Hepatocyte growth factor in lung repair and pulmonary fibrosis , 2011, Acta Pharmacologica Sinica.

[35]  Jessica A. Weber,et al.  The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.

[36]  A. Lindblad,et al.  Gender differences in the Scandinavian cystic fibrosis population , 2010, Pediatric pulmonology.

[37]  A Transfer of miRNA Power♦ , 2010, The Journal of Biological Chemistry.

[38]  Y. Matsuki,et al.  Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.

[39]  R. Stallings,et al.  miR-126 Is Downregulated in Cystic Fibrosis Airway Epithelial Cells and Regulates TOM1 Expression , 2010, The Journal of Immunology.

[40]  Heidi Dvinge,et al.  HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R , 2009, Bioinform..

[41]  R. Aris,et al.  Genetics of Cystic Fibrosis , 2009, Seminars in respiratory and critical care medicine.

[42]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[43]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[44]  L. Kalish,et al.  Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients , 2008, Pediatric pulmonology.

[45]  Charles A. Johnson,et al.  Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. , 2007, The Journal of pediatrics.

[46]  W. Guggino,et al.  Regulation of Cystic Fibrosis Transmembrane Regulator Trafficking and Protein Expression by a Rho Family Small GTPase TC10* , 2005, Journal of Biological Chemistry.

[47]  Tetsuya Matsumoto,et al.  [Pseudomonas aeruginosa infection]. , 2002, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[48]  M. Corey,et al.  Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. , 1997, The Journal of pediatrics.

[49]  P. J. Byard,et al.  Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. , 1995, Journal of clinical epidemiology.

[50]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .